2 active not recruiting, 1 completed. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 2, Completed 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Warm Autoimmune Hemolytic Anemia: new trials by email Literature Review of Warm Autoimmune Hemolytic Anemia trials Research Report on Warm Autoimmune Hemolytic Anemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre) Obexelimab, Placebo - Warm Autoimmune Hemolytic Anemia | Phase 3 | Active not recruiting | Zenas BioPharma (USA), LLC | 134 | 2023-09-25 | 2025-06-25 |
| Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia M281, Placebo - Warm Autoimmune Hemolytic Anemia | Phase 2 / Phase 3 | Active not recruiting | Janssen Research & Development, LLC | 118 | 2019-08-15 | 2026-08-31 |
| Rituximab in Auto-Immune Hemolytic Anemia rituximab (Mabthera®), Placebo - Warm Autoimmune Hemolytic Anemia | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 32 | 2011-03-03 | 2017-10-19 |
Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Rituximab (1)
Assistance Publique - Hôpitaux de Paris (1) · Janssen Research & Development, LLC (1) · Zenas BioPharma (USA), LLC (1)
France (2) · Italy (2) · Poland (2) · Spain (2) · United Kingdom (2) · Brazil (1) · China (1) · Czechia (1) · Egypt (1) · Germany (1) · Greece (1) · Hungary (1) · Israel (1) · Japan (1) · Malaysia (1)
2008 (1), 2019 (1), 2023 (1)